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Summary.The aim of this work was to determine the destructive activity of dextranase, lactoferrin, and lysozyme, against 
single species biofi lms composed of either Klebsiella pneumoniae subsp. pneumoniae or Escherichia coli using the MBEC 
Assay. Luminescence measurements based on quantitation of the ATP present were used to determine the amount of biofi lm 
elimination and correlated with quantity of live bacteria present in the sample. The data were analyzed employing a two-way 
ANOVA and Bonferroni post-test. Treatments resulted in percentage reductions of E. coli biofi lms ranging from 73 to 98 %. 
Lactoferrin (40 μg/ml) produced a signifi cantly higher-percentage reduction than lysozyme (10 μg/ml) (P < 0.05), no other 
signifi cant differences occurred. Similar treatments resulted in percentage reductions of K. pneumoniae subsp. pneumoniae 
biofi lms ranging from 51 to 100 %. Dextranase treatments produced a signifi cantly lower percentage reduction than all other 
materials (P < 0.05), no other signifi cant differences occurred. No material was capable of complete destruction of both single 
species biofi lms; however, low concentrations of lactoferrin and lysozyme each removed 100 % of the K. pneumoniae subsp. 
pneumoniae biofi lm. Low concentrations of lactoferrin or lysozyme might be benefi cial to prevent biofi lm formation by K. pneu-
moniae subsp. pneumoniae. [Int Microbiol 2012; 15(4):183-187]
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Introduction
Approximately 99 % of the microorganisms on Earth exist 
as microbial communities known as biofi lms [5]. Bacterial 
biofi lms occur in a wide variety of natural and human-made 
environments and have been implicated as a constant source of 
pathogens that cause infection and contamination in medical 
and food processing devices [12]. This has led to an increased 
interest in probing the molecular mechanisms fundamental to 
the formation and maintenance of these communities [10]. 
These factors result in serious economic and environmental 
impacts and consequently, a growing need exists for effective 
treatments focusing on biofi lm reduction.
Ölmez and Temur [15] have examined the effect of 
ozone, chlorine and organic acid treatments on the removal 
of Escherichia coli and Listeria monocytogenes embedded 
inside biofi lms on the surface of lettuce leaves. Unfortunately, 
none of these sanitizing treatments are effective in eradi-
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cating the bacteria. Furukawa et al. [6] have reported that 
some strong alkaline or acidic decontamination agents are 
markedly effective for disinfecting Staphylococcus aureus 
biofi lm, as well as E. coli biofi lm. Starek et al. [18] have found 
that toluene reduces average biofi lm biomass and thickness, 
and diminishes the diversity of amplifi able 16S rRNA 
sequences. Regardless of their respective effectiveness, these 
materials are either highly corrosive or not suited to numerous 
environmental decontamination situations. Furukawa et 
al. [6] have also tested the relatively mild agents EDTA 
(ethylenediaminetetraacetic acid), SDS (sodium dodecyl 
sulfate) and Tween 20. These safer compounds, however, 
are ineffective against S. aureus biofi lms and remove only 
partiallly E. coli biofi lms.
No ideal biofi lm decontamination protocol presently 
exists and more innovation is needed to develop an effective, 
relatively robust, and non-corrosive material or cocktail of 
materials. These treatments must be novel, and for successful 
treatment, the materials must both kill the bacteria and detach 
the dead biofi lm by removing the extracellular polymeric 
substances (EPS). Simple disruption of the biofi lm without 
signifi cant cell death permits relocation of viable remnants 
and eventual formation of a new biofi lm [17].
To that end, our research examined three milder 
decontamination substances (dextranase, lactoferrin, and 
lysozyme) for their effi cacy in the destruction of single 
species biofi lms composed of either Klebsiella pneumoniae 
subsp. pneumoniae or E. coli.
Materials and methods
Bacterial biofi lm. Escherichia coli (ATCC 4157) and Klebsiella 
pneumoniae subsp. pneumoniae (ATCC 4352) were cultured on nutrient 
agar (NA) plates overnight at 37 °C. Using a sterile cotton swab, a sample 
of each bacterium was removed from the surface of the overnight culture. 
The bacteria were resuspended at approximately 107 colony forming units 
(CFU)/ml in sterile phosphate-buffered saline (PBS) for use as inoculum in 
the MBEC (minimum biofi lm eliminating concentration) Assay (Innovotech, 
Edmonton, Canada) as per the manufacturer’s directions. Actual inoculum 
range as determined by serial dilution was 3.15 to 6.00 × 107 CFU/ml for 
E. coli and 2.35 to 3.40 × 107 CFU/ml for K. pneumoniae subsp. pneumoniae. 
Each bacterium was run on two-columns of every MBEC plate without any 
treatments applied as controls. One-column was quantifi ed by serial dilution 
plating of the biofi lm after dislodging via sonication from the growth peg to 
determine biofi lm growth rate, and the second-column was quantifi ed in the 
same manner as the treated biofi lms after dislodging via sonication of biofi lm 
from the growth peg.
Treatment material. Treatment concentrations of dextranase (1, 2, 3, and 
4 U/ml; A, B, C, D, respectively); lactoferrin (20, 40, 60, and 80 μg/ml; A, 
B, C, D, respectively) and lysozyme (5, 10, 25, and 50 μg/ml; A, B, C, D, 
respectively) dissolved in PBS were evaluated. PBS was run independent 
of the test material to determine its effect if any on the growth of E. coli 
and K. pneumoniae subsp. pneumoniae, and quantifi ed in the same manner 
as the treated biofi lms after dislodging via sonication of biofi lm from the 
growth peg.
Experimental setup. The experimental design is based on the manufac-
turer’s suggested protocol; the MBEC assay has also been described in de-
tail elsewhere [4,20]. Briefl y, an aliquot of 135 μl of bacterial inoculum was 
added per well to the MBEC plate and incubated at 37 °C while shaking at 
150 rpm overnight. Biofi lm formation was viewed as complete after 24 h. At 
that point, a biofi lm colony concentration of  ≥107 CFU/ml was achieved as 
determined by serial dilution plating of the biofi lm removed from the growth 
peg by sonication. After incubation, the peg lids containing the biofi lm were 
transferred into a rinse plate containing 200 μl/well (PBS) at pH 7.2, and 
incubated for 2 min without agitation at room temperature. The peg lids were 
then transferred into another plate containing 135 μl/well of each treatment. 
Each test material concentration was run in quadruplicate wells. The peg lids 
were then incubated at 37 °C for 1 h.
After treatment, the peg lids were transferred into a rinse as described 
above, and incubated for 2 min without agitation at room temperature 
before being placed into the recovery wells containing 135 ml/well PBS. 
The recovery wells and MBEC peg lids were then subjected to 5 min of 
sonication to dislodge the biofi lm from the peg lids. BacTiter-Glo reagent 
(100 μl/well; Promega, Madison, WI, USA) was added to the suspension, 
and the samples were mixed for 30 s at 150 rpm and then incubated for 5 min 
at room temperature. The luminescence was quantifi ed using a VICTOR3 V 
plate reader (PerkinElmer, Waltham, MA, USA). The resulting live bacterial 
counts were correlated with a standard curve calculated from known bacterial 
quantities. Each experiment was replicated three times.
Statistical analysis. Data were analyzed using commercially available 
statistical software (Prism ver. 5.01, GraphPad Software, La Jolla, CA, USA). 
Within each treatment and bacterial type, a means comparison of concentration 
was performed using a two-way ANOVA followed by Bonferroni post tests to 
determine least square means (P < 0.05).
Results
Figure 1 shows the percentage of reduction in a 24 h old E. coli 
biofi lm achieved after a 1-h exposure to three individual sub-
stances at increasing concentrations. Lactoferrin treatments 
produced the highest-reduction in biofi lm of the three test 
substances, with a range in reduction of 95 to 98 %. Dex-
tranase treatments were the second most effective, reducing 
biofi lm from 81 to 84 %. Lysozyme treatments showed no 
signifi cant difference when compared to the dextranase treat-
ment, reducing the biofi lm from 73 to 84 %. 
Figure 2 shows the percentage of reduction in a 24-h-old 
K. pneumoniae subsp. pneumoniae biofi lm achieved after a 
1-h exposure to the three substances at increasing concentra-
tions. Lactoferrin and lysozyme treatments each produced a 100 
% reduction in biofi lms. Dextranase treatments resulted in 
biofi lm reductions ranging from 51 to 65 %. 
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Escherichia coli and K. pneumoniae subsp. pneumoniae 
biofi lms were compared; K. pneumoniae subsp. pneumoniae 
was signifi cantly more resistant to removal by dextranase 
than was E. coli. Conversely, E. coli was signifi cantly more 
resistant to removal by lysozyme than was K. pneumoniae 
subsp. pneumoniae. Unfortunately, none of the materials 
tested were able to completely eradicate individual biofi lms 
of both E. coli and K. pneumoniae subsp. pneumoniae. PBS 
had no effect on the growth of either of the two bacteria (data 
not shown).
Discussion
Dextranase, lactoferrin, and lysozyme were selected because 
they are capable of destroying the physical integrity of the 
matrix, interfere with bacterial adhesion or initiate cell 
detachment from surfaces in addition to destroying the 
individual bacterial cells. As such, they are good alternatives 
to biocides and/or disinfectants which can contribute to 
the propagation and spread of resistant strains and may 
have restricted use because of environmental regulations. 
Dextranase is an enzyme produced by several bacteria and 
molds which catalyzes the endohydrolysis of 1,6-α-glucosidic 
linkages in dextran resulting in damage to the biofi lm where 
dextran is employed as a key component [7,9]. Lactoferrin is a 
globular glycoprotein widely found in secretory fl uids, whose 
antimicrobial activity results from its iron-binding properties 
which oxidize the bacteria via the formation of peroxides— 
which in turn deprives the bacteria of this essential element 
for growth; disruption of the cell membrane; and targeting 
of H+-ATPase [2,16]. Lysozyme is a glycoside hydrolase 
enzyme found in a number of secretions that disrupts bacterial 
cell walls by catalyzing hydrolysis of 1,4-β-linkages between 
N-acetylmuramic acid and N-acetyl-D-glucosamine residues 
in peptidoglycan and between N-acetyl-D-glucosamine 
residues in chitodextrins [11]. Dextranase, lactoferrin, and 
lysozyme were used at different concentrations to determine 
their effectiveness at eliminating mature single species 
biofi lms of E. coli or K. pneumoniae subsp. pneumoniae. To 
our knowledge, this is the fi rst report of these substances being 
utilized against K. pneumoniae subsp. pneumoniae biofi lms.
Yano et al. [21] have found that dextranase at 0.25 % (v/v) 
produces no signifi cant reduction of Streptococcus mutans or 
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Fig. 1. Percent reduction of the 24-h-old Escherichia coli biofi lm resulting from dextranase, lactoferrin and lysozyme treatments 
at four dosage levels with one 1 h treatment exposure.
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S. sobrinus biofi lms. Our results demonstrated that dextranase 
was the least effective overall of the three substances tested; 
however, against E. coli and K. pneumoniae, it did achieve 
some biofi lm destruction. This difference in fi ndings can 
be explained by the content of dextran and glucans within 
the biofi lm matrix, which is linked to the bacterial species, 
present [1,13,19].
Earlier work with E. coli O157:H7 biofi lms has 
determined that lactoferrin alone is not bacteriostatic, and 
that, at concentrations between 20 and 40 mg/ml, it does 
not prevent the growth of E. coli O157:H7 in tryptic soy 
broth [3,14]. In contrast, we found that lactoferrin was very 
effective to destroy both single species K. pneumoniae subsp. 
pneumoniae and E. coli biofi lms. The difference in outcome 
could partially be explained by the observations of Jenssen and 
Hancock [8], who have reported lactoferrin acting on E. coli by 
damaging the bacterial membrane and disrupting the bacterial 
type III secretion system. These actions would be expected 
to affect the hardiness of a biofi lm formed by this bacterial 
species and thus have a more detrimental effect on biofi lms 
than on planktonic cells.
Previous work has demonstrated the differential effect 
of lysozyme against various bacterial species. Branen and 
Davidson [3] have found that lysozyme has a mean inhibitory 
concentration <500 μg/ml on the growth of E. coli O157:H7. 
In our work, lysozyme at levels as low as 5 μg/ml was 
completely effective (100 %) against K. pneumoniae subsp. 
pneumoniae biofi lms and partially effective (73 %) against 
E. coli biofi lms. The differences between our results and those 
of Branen and Davidson [3] could be caused by the difference 
in species or variant and testing in a planktonic vs. biofi lm 
format.
The results of our study demonstrate the potential of lac-
toferrin as an agent to eradicate mature biofi lms of K. pneu-
moniae subsp. pneumoniae. Further, low concentrations of 
lysozyme or lactoferrin might be benefi cial to prevent bio-
fi lm formation by gram-negative bacteria, such as E. coli and 
K. pneumoniae subsp. pneumoniae, thus providing better 
hygiene in both agricultural and medical arenas. While dex-
tranase achieved biofi lm reduction, it was only partial, which 
minimizes its potential as a control product since biofi lms are 
structured to resist and overcome incomplete degradation. In 
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Fig. 2. Percent reduction of the 24-h-old Klebsiella pneumoniae subsp. pneumoniae biofi lm resulting from dextranase, 
lactoferrin and lysozyme treatments at four dosage levels with 1 h treatment exposure. 
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future work we will examine the effectiveness of these com-
pounds against mature gram-positive biofi lms and mixed-
species biofi lms.
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